Shari D. Bolen

Shari D. Bolen

Auto-generated profile, based on publicly available information

Shari D. Bolen

Case Western Reserve University

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2017 in JMIR Diabetes
Verified
Journal Article
Open access
ASAmy R Sheon
Amy R Sheon
SBShari D Bolen
Shari D Bolen
BCBill Callahan
Bill Callahan
SSSarah Shick
Sarah Shick
APAdam T Perzynski
Adam T Perzynski
Type 2 diabetes (T2D) is one of the nation's leading drivers of disability and health care utilization, with elevated prevalence among individuals with lower education, income, and racial/ethnic minorities. Health information technology (HIT) holds vast potential for helping patients, providers, and payers to address T2D and the skyrocketing rates of chronic illness and associated health care costs. Patient portals to electronic health records (EHRs) serve as a gateway to consumer use of HIT. We found that disparities in portal use portend growing T2D disparities. Little progress has been made in addressing identified barriers to technology adoption, especially among populations with elevated risk of T2D. Patients often lack digital literacy skills and continuous connectivity and fear loss of the relationship with providers. Providers may experience structural disincentives to promoting patient use of HIT and apply hidden biases that inhibit portal use. Health care systems often provide inadequate training to patients and providers in use of HIT, and lack resources devoted to obtaining and optimizing use of data generated by HIT. Lastly, technology-related barriers include inadequate consideration of user perspectives, lack of evidence for patient-focused apps, and lack of features to enable providers and health care systems to readily obtain aggregate data to improve care and facilitate research. After discussing these barriers in detail, we propose possible solutions and areas where further research is needed to ensure that individuals and health care systems obtain the full benefit of the nation's planned $38 billion HIT investment. A digital inclusion framework sheds new light on barriers posed for patients with social health inequalities. We have determined that partnerships with community organizations focused on digital inclusion could help health systems explore and study new approaches, such as universal screening and referral of patients for digital skills, health literacy, and Internet connectivity.

15 April 2014 in Journal of General Internal Medicine
Verified
Journal Article
Closed access
PDF file
SBShari D. Bolen
Shari D. Bolen
ACApoorva Chandar
Apoorva Chandar
CFCorinna Falck-Ytter
Corinna Falck-Ytter
CTCarl Tyler
Carl Tyler
APAdam T. Perzynski
Adam T. Perzynski
DWDonna M. Windish
Donna M. Windish

20 May 2015 in Primary Health Care Research & Development
Verified
Journal Article
Open access
SBShari D. Bolen
Shari D. Bolen
PSPaulette Sage
Paulette Sage
APAdam T. Perzynski
Adam T. Perzynski
KSKurt C. Stange
Kurt C. Stange
Aim: To better understand the type and range of health issues initiated by patients and providers in ‘high-quality’ primary-care for adults with diabetes and low socio-economic status (SES). Background: Although quality of care guidelines are straightforward, diabetes visits in primary care are often more complex than adhering to guidelines, especially in adults with low SES who experience many financial and environmental barriers to good care. Methods: We conducted a qualitative study using direct observation of primary-care diabetes visits at an exemplar safety net practice in 2009–2010. Findings: In a mainly African American (93%) low-income population with fair cardiovascular control (mean A1c 7.5%, BP 134/81 mmHg, and low-density lipoprotein cholesterol 100 mg/dL), visits addressed a variety of bio-psychosocial health issues [median: 25 problems/visit (range 13–32)]. Physicians most frequently initiated discussions about chronic diseases, prevention, and health behavior. Patients most frequently initiated discussions about social environment and acute symptoms followed by prevention and health behavior. Conclusions: Primary-care visits by diabetes patients with low SES address a surprising number and diversity of problems. Emerging new models of primary-care delivery and quality measurement should allow adequate time and resources to address the range of tasks necessary for integrating biomedical and psychosocial concerns to improve the health of socio-economically disadvantaged patients.

26 January 2021 in Journal of General Internal Medicine
Verified
Journal Article
Closed access
PDF file
SBShari D. Bolen
Shari D. Bolen
TLThomas E. Love
Thomas E. Love
DEDouglas Einstadter
Douglas Einstadter
JLJonathan Lever
Jonathan Lever
SLSteven Lewis
Steven Lewis
RCRandall Cebul
Randall Cebul

1 January 2010 in Obesity
Verified
Journal Article
Closed access
PDF file
SBShari D. Bolen
Shari D. Bolen
JCJeanne M. Clark
Jeanne M. Clark
TRThomas M. Richards
Thomas M. Richards
ASAndrew D. Shore
Andrew D. Shore
SGSuzanne M. Goodwin
Suzanne M. Goodwin
JWJonathan P. Weiner
Jonathan P. Weiner

4 October 2018 in BMC Medical Research Methodology
Verified
Journal Article
Open access
PDF file
PBPaul M Bakaki
Paul M Bakaki
JSJennifer Staley
Jennifer Staley
RLRujia Liu
Rujia Liu
NDNeal Dawson
Neal Dawson
NGNegar Golchin
Negar Golchin
SBShari D Bolen
Shari D Bolen
Polypharmacy can be either beneficial or harmful to children. We conducted a scoping review to examine the concept of pediatric polypharmacy: its definition, prevalence, extent and gaps in research. In this manuscript, we report our transdisciplinary scoping review methodology. After establishing a transdisciplinary team, we iteratively developed standard operating procedures for the study’s search strategy, inclusion/exclusion criteria, screening, and data extraction. We searched eight bibliographic databases, screened abstracts and full text articles, and extracted data from included studies using standardized forms. We held regular team meetings and performed ongoing internal validity measurements to maintain consistent and quality outputs. With the aid of EPPI Reviewer collaborative software, our transdisciplinary team of nine members performed dual reviews of 363 included studies after dual screening of 4398 abstracts and 1082 full text articles. We achieved overall agreement of 85% and a kappa coefficient of 0.71 (95% CI 0.68–0.74) while screening full text articles. The screening and review processes required about seven hours per extracted study. The two pharmacists, an epidemiologist, a neurologist, and a librarian on the review team provided internal consultation in these key disciplines. A stakeholder group of 10 members with expertise in evidence synthesis, research implementation, pediatrics, mental health, epilepsy, pharmacoepidemiology, and pharmaceutical outcomes were periodically consulted to further characterize pediatric polypharmacy. A transdisciplinary approach to scoping reviews, including internal and external consultation, should be considered when addressing complex cross-disciplinary questions.